Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by Arno Therapeutics
Sponsor:
Information provided by (Responsible Party):
Arno Therapeutics
ClinicalTrials.gov Identifier:
NCT02052128
First received: January 28, 2014
Last updated: June 22, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2016
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)